Haemophilia · 1996 · 26 citations · 20 references
MedicineGeneticsHematologyHematology PhysiologyHematopathologyHemostasisCoagulation DisordersCoagulation Factor DeficienciesHemolytic DisordersHemostatic DisordersThrombosisThrombotic DisordersFactor V Leiden ThrombophiliaFactor V MutationHereditary Factor V DeficiencyInherited Coagulation Factor DeficienciesProtein C Pathway ImpairmentRare Coagulation Factor DeficienciesThrombosis In Hemolytic DisordersThrombosis Mechanisms
The clinical severity of haemophilia is usually related to residual clotting factor activity. Reports of factor V deficiency or protein C have been described in haemophilic patients and both are involved in the activated protein C pathway. Recently, the poor response to activated protein C due to factor V Leiden (FQ506) has been associated with an increased risk of thrombosis and its incidence in the normal population is given as 2-7%. We describe three cases of severe haemophilia A heterozygous for factor V Leiden and its influence on phenotype.
20
Molecular cloning: A laboratory manual
Prescott L. Deininger · Analytical Biochemistry · 1990 · 86.2K citations
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature · 1994 · 3.8K citations
Medicine, Genetics, Hematology +14
Björn Dahlbäck, Martin Carlsson, Peter J. Svensson · Proceedings of the National Academy of Sciences · 1993 · 2K citations
Ted Koster, FR Rosendaal, Hans de Ronde et al. · The Lancet · 1993 · 1.3K citations
Medicine, Hematology, Hemostasis +14